Travelers With Sickle Cell Disease

被引:14
|
作者
Willen, Shaina M. [1 ]
Thornburg, Courtney D. [2 ]
Lantos, Paul M. [3 ]
机构
[1] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA
[2] Univ San Diego, Med Ctr, Div Pediat Hematol & Oncol, San Diego, CA 92110 USA
[3] Duke Univ, Med Ctr, Div Gen Internal Med, Durham, NC USA
基金
美国国家卫生研究院;
关键词
VENOUS THROMBOEMBOLISM; PNEUMOCOCCAL DISEASE; RISK-FACTORS; CHILDREN; ANEMIA; PROPHYLAXIS; HYDROXYUREA; PENICILLIN; MALARIA; AFRICA;
D O I
10.1111/jtm.12142
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Sickle cell disease (SCD) is the most common genetic disease among persons with African ancestry. This article provides a background to SCD and reviews many important aspects of travel preparation in this population. Methods. The medical literature was searched for studies on travel-associated preparedness and complications in individuals with SCD. Topics researched included malaria, bacterial infections, vaccinations, dehydration, altitude, air travel, and travel preparedness. Results. There is very little published literature that specifically addresses the risks faced by travelers with SCD. Rates of medical complications during travel appear to be high. There is a body of literature that describes complications of SCD in indigenous populations, particularly within Africa. The generalizability of these data to a traveler is uncertain. Combining these sources of data and the broader medical literature, we address major travel-related questions that may face a provider preparing an individual with SCD for safe travel. Conclusions. Travelers with SCD face considerable medical risks when traveling to developing tropical countries, including malaria, bacterial infections, hypovolemia, and sickle cell-associated vaso-occlusive crises. For individuals with SCD, frank counseling about the risks, vigilant preventative measures, and contingency planning for illness while abroad are necessary aspects of the pre-travel visit.
引用
收藏
页码:332 / 339
页数:8
相关论文
共 50 条
  • [1] Current sickle cell disease management practices in Nigeria
    Galadanci, N.
    Wudil, B. J.
    Balogun, T. M.
    Ogunrinde, G. O.
    Akinsulie, A.
    Hasan-Hanga, F.
    Mohammed, A. S.
    Kehinde, M. O.
    Olaniyi, J. A.
    Diaku-Akinwumi, I. N.
    Brown, B. J.
    Adeleke, S.
    Nnodu, O. E.
    Emodi, I.
    Ahmed, S.
    Osegbue, A. O.
    Akinola, N.
    Opara, H. I. O.
    Adegoke, S. A.
    Aneke, J.
    Adekile, A. D.
    INTERNATIONAL HEALTH, 2014, 6 (01): : 23 - 28
  • [2] Sickle cell disease: Reducing the global disease burden
    Mburu, Joy
    Odame, Isaac
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 : 82 - 88
  • [3] The Mortality of Adults With Sickle Cell Disease at a Comprehensive Sickle Cell Center
    Afranie-Sakyi, Jennifer A.
    Randall, Eldrida
    Fasano, Ross
    Mclemore, Morgan L.
    El Rassi, Fuad
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (04) : 663 - 671
  • [4] COVID-19 outcomes in sickle cell disease and sickle cell trait
    Christian, Jana
    Lanzkron, Sophie
    Naik, Rakhi P.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022, 35 (03)
  • [5] Management of sickle cell disease in the community
    Brousse, Valentine
    Makani, Julie
    Rees, David C.
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [6] Genitourinary manifestations of sickle cell disease
    Gebreselassie, Surafel
    Simmons, Matthew N.
    Montague, Drogo K.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2015, 82 (10) : 679 - 683
  • [7] The Natural History of Sickle Cell Disease
    Serjeant, Graham R.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2013, 3 (10):
  • [8] A global perspective on sickle cell disease
    Aygun, Banu
    Odame, Isaac
    PEDIATRIC BLOOD & CANCER, 2012, 59 (02) : 386 - 390
  • [9] Sickle Cell Disease
    Steinberg, Martin H.
    ANNALS OF INTERNAL MEDICINE, 2011, 155 (05)
  • [10] Effects of vaccines in patients with sickle cell disease: a systematic review protocol
    Wiyeh, Alison Beriliy
    Abdullahi, Leila Hussein
    Wonkam, Ambroise
    Wiysonge, Charles Shey
    Kaba, Mamadou
    BMJ OPEN, 2018, 8 (03):